European Biotech Acquisition (European Biotech Acquisition) Pretax Margin % : % (As of Dec. 2022)

View and export this data going back to 2021. Start your Free Trial

What is European Biotech Acquisition Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. European Biotech Acquisition's Pre-Tax Income for the three months ended in Dec. 2022 was $-0.97 Mil. European Biotech Acquisition's Revenue for the three months ended in Dec. 2022 was $0.00 Mil. Therefore, European Biotech Acquisition's pretax margin for the quarter that ended in Dec. 2022 was %.

The historical rank and industry rank for European Biotech Acquisition's Pretax Margin % or its related term are showing as below:

EBACU's Pretax Margin % is not ranked ^*
in the Diversified Financial Services industry.
Industry Median: 4.43
* Ranked among companies with meaningful Pretax Margin % only.

European Biotech Acquisition Pretax Margin % Historical Data

The historical data trend for European Biotech Acquisition's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

European Biotech Acquisition Pretax Margin % Chart

European Biotech Acquisition Annual Data

Trend

Dec21

Dec22

Pretax Margin %

European Biotech Acquisition Quarterly Data
	Jan21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22
Pretax Margin %	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of European Biotech Acquisition's Pretax Margin %

For the Shell Companies subindustry, European Biotech Acquisition's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

European Biotech Acquisition's Pretax Margin % Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, European Biotech Acquisition's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where European Biotech Acquisition's Pretax Margin % falls into.

European Biotech Acquisition Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

European Biotech Acquisition's Pretax Margin for the fiscal year that ended in Dec. 2022 is calculated as

Pretax Margin	=	Pre-Tax Income (A: Dec. 2022 )	/	Revenue (A: Dec. 2022 )
	=	0.343	/	0
	=	%

European Biotech Acquisition's Pretax Margin for the quarter that ended in Dec. 2022 is calculated as

Pretax Margin	=	Pre-Tax Income (Q: Dec. 2022 )	/	Revenue (Q: Dec. 2022 )
	=	-0.969	/	0
	=	%

European Biotech Acquisition (NAS:EBACU) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

European Biotech Acquisition Pretax Margin % Related Terms

Thank you for viewing the detailed overview of European Biotech Acquisition's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

European Biotech Acquisition (European Biotech Acquisition) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » European Biotech Acquisition Corp (NAS:EBACU) » Definitions » Pretax Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

EPFL Innovation Park Building, Lausanne, CHE, 1015

Website

https://www.lspvc.com

European Biotech Acquisition Corp is a blank check company.

Executives

Mohammad Sohail Fazeli	director	JOHANNES VERMEERPLEIN 9, AMSTERDAM P7 1071 DV
Martijn Kleijwegt	director	JOHANNES VERMEERPLEIN 9, AMSTERDAM P7 1071 DV
Volkert H. Doeksen	director	RIOUWSTRAAT 10, THE HAGVE P7 2585HA
Fernandez De Araoz Eduardo Bravo	officer: Chief Executive Officer	JOHANNES VERMEERPLEIN 9, AMSTERDAM P7 1071 DV
Koen Sintnicolaas	officer: Chief Financial Officer	JOHANNES VERMEERPLEIN 9, AMSTERDAM P7 1071 DV
Lsp Sponsor Ebac B.v.	10 percent owner	JOHANNES VERMEERPLEIN 9, AMSTERDAM P7 1071 DV
Van De Stolpe Onno	director	JOHANNES VERMEERPLEIN 9, AMSTERDAM, P7 1071 DV
Marcus Antonius Wegter	director	JOHANNES VERMEERPLEIN 9, AMSTERDAM P7 1071 DV
Lsp Management Group B.v.	10 percent owner	JOHANNES VERMEERPLEIN 9, AMSTERDAM P7 1071 DV

European Biotech Acquisition (European Biotech Acquisition) Headlines

From GuruFocus

European Biotech Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants Commencing May 6, 2021

By Business Wire Business Wire • 05-04-2021

European Biotech Acquisition Corp. Receives Expected Notification from Nasdaq Related to Delayed Quarterly Report

By Business Wire Business Wire • 06-04-2021